Primarily, it impedes the initiation of inflammasomes in both bone marrow-derived macrophages (BMDM) and human pluripotent stem cell-derived macrophages, thereby diminishing the early-stage activation of NLRP3 inflammasomes during viral infection. This evidence concerns the gene NLRP3 and viral infectious disease.